Close Menu

NEW YORK (GenomeWeb) – Trovagene announced today that it has signed an in-network provider agreement with Blue Cross Blue Shield of Illinois, establishing access for plan members to the company's full line of Trovera liquid biopsy tests.

This product line currently includes assays performed on either blood or urine, which detect mutations in EGFR, KRAS, and BRAF.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.